Pyrazine compounds as phosphodiesterase 10 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/12 (2006.01) A61K 31/497 (2006.01) A61P 25/16 (2006.01) A61P 25/18 (2006.01) C07D 403/14 (2006.01) C07D 407/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2742993

Pyrazine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

L'invention concerne des composés de pyrazine et des compositions les contenant, ainsi que des procédés de préparation de ces composés. L'invention concerne également des procédés permettant de traiter des troubles et des maladies pouvant être traitées par inhibition de PDE 10, par exemple l'obésité, les diabètes non-insulino-dépendants, la schizophrénie, le trouble bipolaire, le trouble obsessionnel compulsif, etc.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazine compounds as phosphodiesterase 10 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazine compounds as phosphodiesterase 10 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazine compounds as phosphodiesterase 10 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1543687

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.